We found 2 drugmaker programs for C3 Glomerulopathy medicines. Tell us your insurance below and we'll show what to try first.
Help for C3 Glomerulopathy depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Eligible commercially insured patients may pay as little as $0 for EMPAVELI. Annual benefit limit; not for Medicare, Medicaid, CHIP, VA/DoD or TRICARE.
The Apellis Bridge Program may give a temporary supply of EMPAVELI if your insurance changes or coverage is interrupted.
The Apellis Patient Assistance Program may help people with no insurance or limited coverage get EMPAVELI at no cost.
Care Coordinators explain insurance benefits and schedule deliveries; nurse educators train you to self-inject; vaccine support offered.
Must enroll in ApellisAssist for the copay program. Terms and conditions apply to all programs.
Co-Pay Plus: eligible privately insured patients may pay as little as $0; up to $20,000 a year for Fabhalta plus up to $1,000 for required vaccinations. Not for government insurance.
Privately insured patients with a prior authorization or initial denial may get up to 12 months of Fabhalta free while coverage is pursued.
A dedicated Novartis Patient Support team helps with coverage and ongoing support. Mon-Fri 8 AM-8 PM ET.
Novartis Patient Assistance Foundation provides Fabhalta free to eligible patients who are uninsured or have government insurance and meet income limits.
Free drug is through the separate Novartis Patient Assistance Foundation (1-800-277-2254); income limits apply.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 2 drugmaker programs for C3 Glomerulopathy medicines. We checked every one at the source on or before October 14, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For C3 Glomerulopathy, 0 charity funds on this page accept Medicare, and 1 drugmaker free medicine program names Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
Of the drugmaker programs for C3 Glomerulopathy medicines, 2 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list () on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
